Brownstein Carrie insider trades
Brownstein Carrie has filed 8 Form 4s with the SEC that we hold, for Shattuck Labs, Inc. (STTK) (Director) and Zentalis Pharmaceuticals, Inc. (ZNTL) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 2 sales worth $207.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 8,906 shares of Zentalis Pharmaceuticals, Inc. worth $173.0K, dated 2023-10-04. The first filing on our record is dated 2021-11-17 and the latest 2025-07-16.
Shattuck Labs, Inc. (STTK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-10-04 | S, sale reported on Form 4 | 1,722 | $34.3K | 2023-10-06 |
| 2023-10-04 | S, sale reported on Form 4 | 8,906 | $173.0K | 2023-10-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1894232) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms